Cumulative third-quarter R&D expenses: ¥240 million
First written in FY2017-Q3. 12 of 32 entries say "Advanced", first in FY2017. Latest entry: FY2026.
49 other companies' latest entry also says "Other".
- FY2026Full-Year R&D Expenditure UpdatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥468 million.」
Full-year R&D expenses were updated to ¥468 million, down from ¥579 million in the previous fiscal year, while development of plus FOG, space-related areas, EQ guidance, VoOE LS and other areas was disclosed. - FY2026-H1Interim R&D Expense UpdateAnnual report
「Total R&D expenses for the current consolidated interim period were ¥234 million.」
R&D expenses for the interim period were disclosed at ¥234 million, with no material changes in the status of R&D activities. - FY2025AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥579 million.」
Full-year R&D expenses were ¥579 million, up from ¥479 million in the previous fiscal year. The Group is expanding its R&D fields to include particle visualization, suppression of room-pressure fluctuations, decarbonization, low-temperature waste heat, and space-related areas. - FY2025-H1Interim R&D Expense UpdateAnnual report
「Total R&D expenses for the current consolidated interim period were ¥228 million. There were no material changes in the status of the Group's R&D activities during the current consolidated interim period.」
R&D expenses for the current consolidated interim period were disclosed at ¥228 million. It stated that there were no material changes in the status of R&D activities. - FY2024AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥479 million.」
Full-year R&D expenses were disclosed at ¥479 million, up from ¥477 million in the previous fiscal year. - FY2024-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥330 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were updated to ¥330 million, with no material changes in the status of R&D activities. - FY2024-Q2Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥218 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were updated to ¥218 million, with no material changes in the status of R&D activities. - FY2024-Q1Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥103 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were disclosed at ¥103 million, with no material changes in the status of R&D activities. - FY2023-Q3Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥335 million.」
R&D expenses for the cumulative third quarter were disclosed at ¥335 million, up from ¥313 million in the same period of the previous fiscal year, while it stated that there were no material changes in the status of R&D activities. - FY2023-Q2Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥215 million.」
R&D expenses for the cumulative second quarter were disclosed at ¥215 million. - FY2023-Q1Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥106 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were disclosed at ¥106 million. It stated that there were no material changes in the status of R&D activities. - FY2022-Q3Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥313 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were disclosed at ¥313 million. It stated that there were no material changes in the status of R&D activities. - FY2022-Q2Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥207 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were disclosed at ¥207 million, with no material changes in the status of R&D activities. - FY2022-Q1Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥86 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were ¥86 million, down from ¥90 million in the same period of the previous fiscal year. It stated that there were no material changes in the status of R&D activities. - FY2021AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥477 million.」
Full-year R&D expenses were ¥477 million, up from ¥417 million in the previous fiscal year. - FY2021-Q3Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥296 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were disclosed at ¥296 million, with no material changes in the status of R&D activities. - FY2021-Q2Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥185 million.」
R&D expenses for the cumulative second quarter were disclosed at ¥185 million, down ¥5 million from ¥190 million in the same period of the previous fiscal year. It also stated that there were no material changes in the status of R&D activities. - FY2021-Q1Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥90 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were disclosed at ¥90 million, with no material changes in the status of R&D activities. - FY2020Full-year R&D expense updatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥417 million.」
Full-year R&D expenses were disclosed at ¥417 million, down ¥5 million from ¥422 million in the previous fiscal year. - FY2020-Q3Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the nine months ended the current third quarter were ¥291 million.」
The company disclosed R&D expenses of ¥291 million for the nine months ended the third quarter, down ¥7 million from ¥298 million in the same period of the previous year. - FY2020-Q2AdvancedAnnual report
「Total R&D expenses for the six months ended the current second quarter were ¥191 million.」
The company disclosed R&D expenses of ¥191 million for the six months ended the current second quarter, up ¥1 million from ¥190 million in the same period of the previous year. - FY2020-Q1Update to quarterly R&D expensesAnnual report
「Total R&D expenses for the three months ended the current first quarter were ¥92 million.」
The company disclosed R&D expenses of ¥92 million for the three months ended the current first quarter, down ¥4 million from ¥96 million in the same period of the previous year. - FY2019AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥422 million.」
Full-year R&D expenses increased from ¥374 million in the previous fiscal year to ¥422 million. - FY2019-Q3AdvancedAnnual report
「Total R&D expenses for the nine months ended the current third quarter were ¥298 million.」
The company disclosed R&D expenses of ¥298 million for the nine months ended the current third quarter, up from ¥261 million in the same period of the previous year. - FY2019-Q2AdvancedAnnual report
「Total R&D expenses for the six months ended the current second quarter were ¥190 million.」
The company disclosed R&D expenses of ¥190 million for the six months ended Q2 FY2019. - FY2019-Q1AdvancedAnnual report
「Total R&D expenses for the three months ended the current first quarter were ¥96 million.」
The company disclosed R&D expenses of ¥96 million for the three months ended Q1 FY2019. - FY2018Full-year R&D expense updatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥374 million.」
The company disclosed full-year R&D expenses of ¥374 million. - FY2018-Q3AdvancedAnnual report
「Total R&D expenses for the nine months ended the current third quarter were ¥261 million.」
R&D expenses were updated from ¥240 million in the same period of the previous year to ¥261 million for the nine months ended the current third quarter. - FY2018-Q2AdvancedAnnual report
「Total R&D expenses for the six months ended the current second quarter were ¥165 million.」
The company disclosed R&D expenses of ¥165 million for the six months ended Q2 FY2018. - FY2018-Q1AdvancedAnnual report
「Total R&D expenses for the three months ended the current first quarter were ¥77 million.」
The company disclosed R&D expenses of ¥77 million for the nine months ended Q1 FY2018. - FY2017AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥396 million.」
Full-year R&D expenses were ¥396 million, updated from ¥240 million for the nine months ended the third quarter. - FY2017-Q3First statedAnnual report
「Total R&D expenses for the nine months ended the current third quarter were ¥240 million.」
The company disclosed total R&D expenses of ¥240 million for the nine months ended the third quarter.